Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D02TVQ
|
||||
| Former ID |
DIB019955
|
||||
| Drug Name |
GSK343
|
||||
| Synonyms |
compound 6 [PMID 24900432]; GSK 343
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [532811] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C31H39N7O2
|
||||
| InChI |
InChI=1S/C31H39N7O2/c1-6-7-23-14-21(4)35-31(40)26(23)18-33-30(39)25-15-24(16-28-27(25)19-34-38(28)20(2)3)22-8-9-32-29(17-22)37-12-10-36(5)11-13-37/h8-9,14-17,19-20H,6-7,10-13,18H2,1-5H3,(H,33,39)(H,35,40)
|
||||
| InChIKey |
ULNXAWLQFZMIHX-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | Enhancer of zeste homolog 2 | Target Info | Inhibitor | [532811] | |
| enhancer of zeste 1 polycomb repressive complex 2 subunit | Target Info | Inhibitor | [532811] | ||
| KEGG Pathway | MicroRNAs in cancer | ||||
| NetPath Pathway | IL2 Signaling Pathway | ||||
| WikiPathways | Interactome of polycomb repressive complex 2 (PRC2) | ||||
| Endoderm Differentiation | |||||
| Integrated Pancreatic Cancer Pathway | |||||
| Histone Modifications | |||||
| Cell Differentiation - meta | |||||
| miRs in Muscle Cell Differentiation | |||||
| miR-targeted genes in muscle cell - TarBase | |||||
| miR-targeted genes in lymphocytes - TarBase | |||||
| miR-targeted genes in epithelium - TarBase | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.